MAPT and Alzheimer disease: Figure 3 shows visual comparison of brain regions with higher [18-F]AV1451 PET tau signal among the FTLD-AD, compared to the FTLD-non-AD group (unadjusted p < 0.001; extent threshold, k = 50).